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Transpapillary stents are increasingly being used for biliary strictures, whether benign or malignant. However, there are diﬀerent
stent types and available data is controversial. Recently, completely covered self-expandable metal stents (CSEMSs) have been
proposedasanalternativetherapeuticoptionindiﬀerentbiliaryindications,includingstricturesofthedistalbileduct,anastomotic
stenosis after orthotopic liver transplantation, bile duct leaks, periampullary perforation following endoscopic sphincterotomy
(ES), and postsphincterotomy bleeding. Despite the higher costs of these devices, fully covered self-expanding metal stents seem
to be a suitable therapeutic option to relief biliary obstruction due to bile duct stenosis, regardless of the underlying cause.
1.Introduction
A multicenter trial comparing preoperative biliary drainage
to early surgery for cancer of the pancreatic head showed
that routine preoperative biliary drainage increased the rate
of complications signiﬁcantly [1]. The authors concluded
that it should not be used routinely. Although drainage was
primarily successful in 94%, there was a signiﬁcant rate of
cholangitis and a rate of 30% for the need of stent exchange
leading to more readmissions. In addition, surgeons often
reportthattheyfeelthatanastomosisoftheremainingbiliary
t r a c tt ot h ej e j u n a ll o o pi sm o r ed i ﬃcult and hampered
becauseofthelocalinﬂammationcausedbythestent.Never-
theless,inthetrialabove,plasticstentshavebeenused.These
stents have a narrow diameter which results in a high rate of
stent occlusion over time with consequent cholangitis. This
problem can partially be overcome using wide-bore stents
such as self-expanding metal stents [2]. The disadvantage of
these devices, however, is that once positioned they cannot
be removed eﬀortlessly without major damage to the biliary
duct. Recently, completely covered self-expanding metal
stents (CSEMSs) have become available making removal
either endoscopically or during surgery easily possible.
Accordingly, fully covered self-expandable metal stents have
been lately used for the management of various malignant as
well as benign biliary disorders, including strictures of the
distal bile duct, anastomotic stenosis after orthotopic liver
transplantation, and postsphincterotomy bleeding.
Recent data demonstrated that biliary drainage can be
achieved using fully covered self-expanding metal stents
regardless of the underlying disease, be it benign or malig-
nant. These stents were not associated with a higher rate of
complication compared to noncovered self-expanding metal
stents or plastic stents. In contrast to the latter a much lower
rate of occlusion and subsequent cholangitis was observed.
2.FullyCoveredSelf-Expandable MetalStents
for Treatment of Malignant Biliary Strictures
Pancreatic cancer is the most common cause of malignant
biliary obstruction. Jaundice occurs in 70–90% of the
patients during the course of the disease.
In the past, plastic stents were used in the ﬁrst instance
in the palliative care of these patients to relieve biliary
obstruction; however, in this setting self-expandable metal
stents have been increasingly used due to their long term
patency. Compared with uncovered metal stents, covered
m e t a ls t e n t sh a v el o n g e rp a t e n c ya n dal o w e rr a t eo ft u m o r
ingrowth, and have a higher rate of stent migration [3].2 Diagnostic and Therapeutic Endoscopy
A randomized controlled trial comparing covered and
uncovered metal stents in patients with malignant biliary
obstruction showed a longer stent patency of covered (304
days) compared with uncovered stents (161 days) [4].
Preoperative biliary drainage using plastic stents in
patients with pancreatic carcinoma has been shown to be
inferior to early surgery and is associated with high rates of
serious complications [1]. In the trial above, plastic stents
have been used. These stents have a narrow diameter which
results in a high rate of stent occlusion over time with
consequent cholangitis.
In a study including 101 patients with pancreatic car-
cinoma, CSEMSs were placed for biliary decompression
regardless of respectability. In 85 patients who did not
undergo resection the mean patency duration of CSEMS
was 5,5 months. Moreover, this treatment option seems to
be a less costly intervention compared with other treatment
options [5].
This is also in accordance with a recent report from
Philadelphia, in which the authors recommend fully covered
self-expanding stents as the initial intervention for biliary
obstruction even if the surgical respectability status is
uncertain [6].
Theprolongedpatencyandextractabilityofthesedevices
make them an attractive treatment option in patients with
pancreatic carcinoma regardless of respectability.
3. CSEMS for Treatment of
Benign BiliaryStrictures
The most common causes of benign biliary stenosis are
postsurgical and chronic pancreatitis [7].
Plastic stents have been traditionally used to treat benign
biliary disorders because of their extractability and low costs.
In a systemic review published in 2009 including 47 studies
(1116 patients) comparing plastic stents (single or multiple)
and uncovered self-expandable metal stents in management
of benign biliary strictures, multiple plastic stents appeared
to be more eﬀective [8]. However, this data was collected
before the CSEMS era.
InaprospectivestudyCSEMSswereplacedin44patients
with benign biliary strictures due to diﬀerent etiologies
(chronic pancreatitis in 19 patients, gall stones related
strictures in 14 patients, post-liver-transplant stenosis in
nine patients, autoimmune pancreatitis in one patient and
primary sclerosing cholangitis in one patient). The median
time of stent placement was 3.3 months. Resolution of
strictures was documented in 34 patients (77%) after a
median poststent removal follow-up time of 3.8 months [9].
However, in patients with chronic pancreatitis endoscopic
therapy was less successful compared with the other etiolo-
gies (58% versus 92%). These results are in accordance with
the results of older studies in which plastic stents were used
to treat biliary strictures in this setting. Chronic pancreatitis,
especially calciﬁc pancreatitis, seems to be less responsive to
endoscopic therapy with a higher recurrence rate [7].
4. CSEMS for Treatment of Anastomosis
StenosisFollowing LiverTransplantation
The most common complication after liver transplantation
is anastomotic stricture with an incidence of up to 15% in
deceaseddonorlivertransplantation[10],followedbybiliary
leakage.
In a small series, including 11 patients with complica-
tions after liver transplantation, eight of whom with biliary
stenosis and three with biliary leakage, placement of CSEMS
was successful in avoiding hepaticojejunostomies in six from
nine patients [11].
Inarecentlypublishedpaperwhichincluded54consecu-
tive patients with biliary complications following orthotopic
liver transplantation CSEMS proved to be successful in
patients in whom standard endoscopic therapy failed. The
authors concluded that metal stents should not be used as
the primary treatment modality; however, after failure of
conventional endoscopic therapy, temporary placement of
CSEMS solved biliary problems in almost three-quarters of
the patients [12].
In this setting, however, stent migration seems to be a
relevant problem occurring in between 30 and 50% of the
cases, although presenting with no clinical consequences in
most patients [11, 13].
We hypothesise that stent dislocation in anastomotic
strictures following liver transplantation represents an indi-
cator of the eﬀectiveness of this therapy, as the currently
patent bile duct cannot hold the stent any more in position.
Furthermore, there were no serious complications associated
withspontaneousstentmigration.Inouropinion, inanasto-
motic stricture complicating liver transplantation scheduled
ERC by no later than eight weeks after stent implantation
should be performed, in order that early/incomplete stent
dislocation/migration can be detected, and if necessary
correctionofstentpositionorremovalofdislocatedstentcan
be achieved.
New development, like anchoring ﬂap at the proximal
end of the stent may be an option as well to prevent this
complication [14].
Not only in anastomotic stenosis following liver trans-
plantation and distal biliary strictures, but also in hilar
strictures CSEMS appears to be a therapeutic alternative
without fear of occlusion of the contralateral hepatic duct,
as shown in a recent paper [15]. Nevertheless, because of the
very small number of cases, further evaluation is necessary.
5. CSEMS for Treatment of
Postsphincterotomy Bleeding
Bleedingisoneofthemostcommoncomplicationsfollowing
endoscopic sphincterotomy.The incidence of postsphinc-
terotomy bleeding reported in the literature widely varies
because of diﬀerences in deﬁnition and may reach up to 10%
[16].
Established risk factors of bleeding include uncorrected
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within three days prior to the procedure, and acute cholan-
gitis. In addition, the presence of a periampullary diver-
ticulum, the use of precut technique, and low endoscopist
experience may increase the risk of bleeding [17].
As most of the bleeding episodes stop spontaneously,
endoscopic therapy is preserved for endoscopically signif-
icant immediate bleeding and clinically relevant delayed
bleeding.
Endoscopic therapy includes injection, thermal, and
mechanical therapy using balloon tamponade or endoclips.
Injection of diluted epinephrine (1:10,000) in and around
the sphincterotomy site is the most commonly used method,
whereas the amount of injected solution may vary from 0,5
to 30mL [18].
Nevertheless, application of endoscopic therapy may
be technically very demanding due to failure of exact
localization of the bleeding site during severe hemorrhage
and diﬃculty in maneuvering instruments through a side-
view endoscope. Furthermore, the risk of pancreatitis may
increase if endoscopic combination therapy is applied [19].
In a recent retrospective analysis including 11 patients,
hemostasis was achieved in all patients using CSEMS after
failure of other measures. The mean duration of stent place-
ment was 8,2 days and all stents were successfully removed
endoscopically [20]. In another case series, including ﬁve
patients CESMS were eﬀective to control bleeding in all
patients. The stents were removed within eight weeks in
three patients and migrated spontaneously without clinical
sequelae in two patients [21].
A further advantage of this treatment modality is the
simultaneous and eﬀective drainage of the bile duct, espe-
cially if occluded with blood clots.
6. CSEMS for Treatment of Biliary Leaks
Biliary leak is not an uncommon complication following
hepatobiliary surgery. Leaks are treated with endoscopic
sphincterotomy with or without stenting reducing the
intraductal pressure and thus diverting the ﬂow form the
leakingsite.Plasticstentshavebeenusedtraditionallyforthis
indication; however, CSEMS may provide a further eﬀective
therapeutic option. The large diameter of these stents allows
an eﬀective drainage away for the leakage site. Furthermore,
placingthestentacrosstheinjuredsitemayhelptosealit[7].
In a retrospective analysis including 13 patients with
complex biliary leaks (eight following cholecystectomy and
ﬁve after liver transplantation) CSEMSs with anchoring ﬁns
were temporarily placed. Successful resolution of the leaks
was achieved in all patients, though two patients developed
strictures after stent removal. Furthermore, this treatment
modality was associated with bile duct ulcerations and de
novo choledocholithiasis [22].
7. CSEMS for Treatment of
ERCP-AssociatedPerforations
ERCP-associated perforation may be due to endoscope
passage leading to lateral duodenal wall injury (type I),
periampullary following endoscopic sphincterotomy (type
II), and ductal (type III) resulting from guide wire insertion.
Type I perforations are usually large and require imme-
diate surgical treatment.
On the other hand, type II perforations due to guide
wire or basket insertion are typically small, tend to heal
spontaneously, and are generally treated conservatively [23].
The management of periampullary perforations remains
controversial. Some authors recommend immediate endo-
scopic treatment with diversion of bile from the perforation
site using bile duct stents or nasobiliary tubes once retroperi-
toneal perforation is recognized during the procedure [23].
CSEMS represents a new endoscopic therapeutic option
sealing the perforation site and permitting free bile ﬂow into
the duodenum.
8.Removal ofCSEMS
So far, only plastic stents could be removed safely endoscop-
ically if necessary. The disadvantage of these stents, however,
is the small internal diameter which predisposes to occlusion
by biliary sludge. With the availability of fully covered self-
expanding stents this short coming has been overcome.
In a multicenter study, including 37 patients removal
attempts of the CSEMS were successful in all cases [24]. The
endoscopic feasibility and safety of stent removal were also
documented by other authors [25].
9. Complications
Cholecystitis is not an uncommon complication following
placement of CSEMS as the outlet of the cystic duct into the
common bile duct can be blocked by the stent. We suggest
that this complication should be avoided by using a stent
length with the upper end distal to the cystic duct outlet. In
one study, this complication occurred in 20% of cases if the
CSEMS covered the cystic duct. A gallbladder stent (seven
French transpapillary pigtail gallbladder stent) was eﬀective
in reducing the risk of developing cholecystitis after CSEMS
placement [26].
Stent migration represents a frequent complication of
CSEMS when placed for treatment of benign biliary stric-
tures and has already been discussed above. Recently new
stents were developed (anchoring ﬂap) to decrease stent
migration.
10. Conclusion
Despite the higher costs of these devices, fully covered
self-expandable metal stents are suitable to relief biliary
obstruction due to bile duct stenosis, regardless of the
underlying cause. Stent length should be chosen as short as
possible to avoid any alteration of the proximal common
bile duct. The internal diameter of 8–10mm of these stents
ascertains suﬃcient bile ﬂow, if bile is very viscous because
of previous biliary obstruction. Removal of the stents can be
achieved smoothly in all cases if desired.4 Diagnostic and Therapeutic Endoscopy
CSEMS are also an eﬀective treatment option in biliary
leaks, type II perforation following ES, and severe post-
sphincterotomy bleeding, not controlled by other measures.
Prospective multicenter trials should be carried out to
evaluate further the eﬀectiveness of CSEMS in benign and
malignant biliary disorders.
11. Key Issues
The Key issues include the following.
(i) Fully covered self-expandable metal stents have been
lately used for the management of various malignant
as well benign biliary disorders.
(ii) Recent reports demonstrated that biliary drainage
can be achieved using fully covered self-expanding
metal stents regardless of the underlying disease, be
it benign or malignant.
(iii) CSEMS can be also applied to treat biliary leaks fol-
lowing hepatobiliary surgery and type II perforation
due to ES.
(iv) CSEMS is an eﬀective therapeutic option for treat-
ment of postsphincterotomy bleeding not controlled
by other measures.
(v) CSEMS can be removed easily either endoscopically
or during surgery.
(vi) Stent migration seems to be a relevant problem in
benign indications occurring in up to 50% of the
cases.
(vii) Cholecystitis is not an uncommon complication
following placement of CSEMS as the outlet of the
cystic duct into the common bile duct can be blocked
by the stent.
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